rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Cheryl Gault

Chief Operating Officer

Company insider

Files Form 4 as: Chief Operating Officer, Rapport Therapeutics; Chief Operating Officer, Cyclerion Therapeutics.

Every Form 4 they filed

In numbers

Trades disclosed
29
Buys
0
Sells
6
Bought
$0
Sold
$2.2M
Companies
2
Companies where not an officer
0
First trade
9 Dec 2021
Last trade
30 Sep 2026
Last filed
1 Oct 2026

Companies traded

Where they are an officer
RAPP Rapport TherapeuticsOfficer · Biotechnology · last 30 Sep 20260 buys · 6 sells
Cyclerion TherapeuticsOfficer · Biotechnology · last 20 Jan 20220 buys · 0 sells

Activity over time

1 Sep 2025 – 1 Oct 2026
20Sep 25Dec 25Apr 26Jul 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
30 Sep 2026filed 1 Oct 2026RAPP Rapport TherapeuticsBiotechnologySEC FORM 4 Sold$262K7,925 at $33.04filing
30 Sep 2026filed 1 Oct 2026RAPP Rapport TherapeuticsBiotechnologySEC FORM 4 Sold$70K2,075 at $33.76filing
30 Jun 2026filed 1 Jul 2026RAPP Rapport TherapeuticsBiotechnologySEC FORM 4 Sold$76K1,900 at $40.09filing
30 Jun 2026filed 1 Jul 2026RAPP Rapport TherapeuticsBiotechnologySEC FORM 4 Sold$157K3,792 at $41.39filing
30 Jun 2026filed 1 Jul 2026RAPP Rapport TherapeuticsBiotechnologySEC FORM 4 Sold$140K3,308 at $42.17filing
30 Jun 2026filed 1 Jul 2026RAPP Rapport TherapeuticsBiotechnologySEC FORM 4 Sold$43K1,000 at $43.15filing
30 Jun 2026filed 1 Jul 2026RAPP Rapport TherapeuticsBiotechnologySEC FORM 4 Sold$76K1,900 at $40.09filing
30 Jun 2026filed 1 Jul 2026RAPP Rapport TherapeuticsBiotechnologySEC FORM 4 Sold$157K3,792 at $41.39filing
30 Jun 2026filed 1 Jul 2026RAPP Rapport TherapeuticsBiotechnologySEC FORM 4 Sold$139K3,308 at $42.17filing
30 Jun 2026filed 1 Jul 2026RAPP Rapport TherapeuticsBiotechnologySEC FORM 4 Sold$43K1,000 at $43.15filing
30 Mar 2026filed 31 Mar 2026RAPP Rapport TherapeuticsBiotechnologySEC FORM 4 Sold$201K7,161 at $28.04filing
30 Mar 2026filed 31 Mar 2026RAPP Rapport TherapeuticsBiotechnologySEC FORM 4 Sold$81K2,839 at $28.55filing
30 Mar 2026filed 31 Mar 2026RAPP Rapport TherapeuticsBiotechnologySEC FORM 4 Sold$201K7,161 at $28.04filing
30 Mar 2026filed 31 Mar 2026RAPP Rapport TherapeuticsBiotechnologySEC FORM 4 Sold$81K2,839 at $28.55filing
5 Mar 2026filed 9 Mar 2026RAPP Rapport TherapeuticsBiotechnologySEC FORM 4 Sold$58K2,014 at $28.93filing
5 Mar 2026filed 9 Mar 2026RAPP Rapport TherapeuticsBiotechnologySEC FORM 4 Sold$58K2,014 at $28.93filing
2 Feb 2026filed 4 Feb 2026RAPP Rapport Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—132,000 at $0.00filing
2 Feb 2026filed 4 Feb 2026RAPP Rapport Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—132,000 at $0.00filing
26 Nov 2025filed 1 Dec 2025RAPP Rapport Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code M—5,000 at $0.00filing
26 Nov 2025filed 1 Dec 2025RAPP Rapport TherapeuticsBiotechnologySEC FORM 4 Code M$9,0005,000 at $1.80filing

Sectors

Health Care6

Buys in green, sells in red, by the company’s sector.

Related people

Troy A. IgnelziChief Financial Officer · Chief Financial Officer at Rapport Therapeutics, filing Form 4 there in the last year
Abraham CeesayChief Executive Officer · Chief Executive Officer at Rapport Therapeutics, filing Form 4 there in the last year
Andrew GottesdienerDirector · Director at Korsana Biosciences, filing Form 4 there in the last year
Fairmount Funds Management LLCDirector and 10% owner · Director and 10% owner at Korsana Biosciences, filing Form 4 there in the last year
Nimish P. ShahDirector · Director at Korsana Biosciences, filing Form 4 there in the last year
Krishnaswamy YeleswaramChief Development Officer · Also traded RAPP in the last 90 days